• News
  • Stock Screener
  • Small Caps
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Review
  • X (Twitter)

Stock Screener

Show:

Sort

Country

Sector

Risk rating

1
2
3
4
5
6
7

Risk factors

    Default risk

    1
    2
    3
    4
    5
    6
    7

    Volatility

    1
    2
    3
    4
    5
    6
    7

    Stress test

    1
    2
    3
    4
    5
    6
    7

    Selling difficulty

    1
    2
    3
    4
    5
    6
    7

    Country risks

    1
    2
    3
    4
    5
    6
    7

    Other risks

    1
    2
    3
    4
    5
    6
    7

Profitability factors

    Valuation

    1
    2
    3
    4
    5
    6
    7

    Analyst view

    1
    2
    3
    4
    5
    6
    7

    Performance

    1
    2
    3
    4
    5
    6
    7

    Profitability

    1
    2
    3
    4
    5
    6
    7

    Growth

    1
    2
    3
    4
    5
    6
    7

    Dividends

    1
    2
    3
    4
    5
    6
    7

    Results: 560

    WuXi AppTec Co., Ltd.

    603259.SS
    4

    Jiangsu Hengrui Medicine Co., Ltd.

    600276.SS
    4

    Hybio Pharmaceutical Co., Ltd.

    300199.SZ
    2

    Pharmaron Beijing Co., Ltd.

    300759.SZ
    3

    Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

    300760.SZ
    5

    Akeso, Inc.

    9926.HK
    2

    INNOVENT BIO

    1801.HK
    2

    Fujian Cosunter Pharmaceutical Co., Ltd.

    300436.SZ
    2

    CSPC PHARMA

    1093.HK
    5

    WuXi Biologics

    2269.HK
    3

    Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

    300255.SZ
    2

    Gan & Lee Pharmaceuticals.

    603087.SS
    4

    Sino Medical Sciences Technology Inc.

    688108.SS
    3

    3SBIO

    1530.HK
    4

    Joinn Laboratories

    603127.SS
    3

    Zhejiang Huahai Pharmaceutical Co., Ltd.

    600521.SS
    4

    Aier Eye Hospital Group Co., Ltd.

    300015.SZ
    3

    Guangdong Zhongsheng Pharmaceutical Co., Ltd.

    002317.SZ
    4

    Thalys Medical Technology Group Corporation

    603716.SS
    1

    Staidson

    300204.SZ
    2
X-channel

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • X (Twitter)
Oninvest© 2025